Microneedle Patches for Transdermal Vaccine Delivery: Challenges and Clinical Outlook

Abstract

The development of effective vaccine delivery systems remains a major focus of modern biomedical research. Conventional vaccine administration primarily relies on hypodermic needles, which are associated with several limitations, including needle-related anxiety, the need for trained healthcare personnel, generation of biohazardous waste, and challenges in large-scale immunization programs. Microneedle patches have emerged as a promising alternative for transdermal vaccine delivery by enabling painless, minimally invasive administration directly through the skin. The skin contains a dense network of immune cells, making it an attractive target for vaccine delivery and immune stimulation. Microneedle technology has demonstrated the potential to improve vaccine stability, enhance patient compliance, and facilitate self-administration. Despite encouraging preclinical and clinical findings, several barriers continue to hinder widespread implementation, including manufacturing complexities, regulatory considerations, long-term safety evaluation, and scalability. This review examines the principles of microneedle-based vaccine delivery, discusses various microneedle designs, highlights current challenges, and evaluates the future clinical prospects of this technology.

Keywords